Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees.

Ergönül Ö, Tülek N, Kayı I, Irmak H, Erdem O, Dara M.

Clin Microbiol Infect. 2019 Jul 5. pii: S1198-743X(19)30367-2. doi: 10.1016/j.cmi.2019.06.022. [Epub ahead of print] Review.

PMID:
31284037
2.

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe.

Migliori GB, Nardell E, Yedilbayev A, D'Ambrosio L, Centis R, Tadolini M, van den Boom M, Ehsani S, Sotgiu G, Dara M.

Eur Respir J. 2019 Jun 5;53(6). pii: 1900391. doi: 10.1183/13993003.00391-2019. Print 2019 Jun.

PMID:
31023852
3.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

4.

Prioritising children and adolescents in the tuberculosis response of the WHO European Region.

Gröschel MI, van den Boom M, Migliori GB, Dara M.

Eur Respir Rev. 2019 Mar 14;28(151). pii: 180106. doi: 10.1183/16000617.0106-2018. Print 2019 Mar 31. Review.

5.
6.

Hunger and tuberculosis: two sides of the same coin.

Dara M, Zachariah R.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):592. doi: 10.5588/ijtld.18.0279. No abstract available.

PMID:
29862939
7.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

Migliori GB, Sotgiu G, Rosales-Klintz S, Centis R, D'Ambrosio L, Abubakar I, Bothamley G, Caminero JA, Cirillo DM, Dara M, de Vries G, Aliberti S, Dinh-Xuan AT, Duarte R, Midulla F, Solovic I, Subotic DR, Amicosante M, Correia AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S, Verduin R, van der Werf MJ.

Eur Respir J. 2018 May 17;51(5). pii: 1702678. doi: 10.1183/13993003.02678-2017. Print 2018 May.

PMID:
29678945
8.

Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.

Pavlenko E, Barbova A, Hovhannesyan A, Tsenilova Z, Slavuckij A, Shcherbak-Verlan B, Zhurilo A, Vitek E, Skenders G, Sela I, Cabibbe AM, Cirillo DM, de Colombani P, Dara M, Dean A, Zignol M, Dadu A.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):197-205. doi: 10.5588/ijtld.17.0254.

PMID:
29506617
9.

People- and patient-centred care for tuberculosis: models of care for tuberculosis.

Odone A, Roberts B, Dara M, van den Boom M, Kluge H, McKee M.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):133-138. doi: 10.5588/ijtld.17.0608.

PMID:
29506609
10.

Ending tuberculosis calls for leaving no one behind.

Dara M, Zachariah R.

Lancet Infect Dis. 2018 Apr;18(4):365-366. doi: 10.1016/S1473-3099(17)30746-6. Epub 2018 Jan 8. No abstract available.

11.

Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician-public health alliances.

van der Werf MJ, Sotgiu G, Dara M.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701758. doi: 10.1183/13993003.01758-2017. Print 2017 Nov. No abstract available.

12.

Low Rate of babA2 Genotype among Iranian Helicobacter pylori Clinical Isolates.

Sohrabi M, Khashei R, Alizadeh M, Asl MH, Nejati MA, Dara M, Bazargani A.

J Clin Diagn Res. 2017 Jul;11(7):DC32-DC36. doi: 10.7860/JCDR/2017/24810.10277. Epub 2017 Jul 1.

13.

Fighting drug-resistant tuberculosis in eastern Europe.

Drobniewski F, Ehsani S, Dara M.

Lancet Infect Dis. 2017 Jul;17(7):691-692. doi: 10.1016/S1473-3099(17)30330-4. Epub 2017 Jun 21. No abstract available.

14.

Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences.

Dara M, Sulis G, Centis R, D'Ambrosio L, de Vries G, Douglas P, Garcia D, Jansen N, Zuroweste E, Migliori GB.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):727-736. doi: 10.5588/ijtld.16.0940.

PMID:
28633696
15.

High frequency of hopQ genotypes among Iranian Helicobacter pylori clinical isolates.

Dara M, Khashei R, Dehghani B.

Infez Med. 2017 Jun 1;25(2):123-126.

16.

Standard operating procedures for tuberculosis care.

Solovic I, Abubakar I, Sotgiu G, Dara M, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Ward B, Teixeira V, Gratziou C, Migliori GB.

Eur Respir J. 2017 Jun 1;49(6). pii: 1700515. doi: 10.1183/13993003.00515-2017. Print 2017 Jun. No abstract available.

17.

Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan.

Gadoev J, Asadov D, Harries AD, Parpieva N, Tayler-Smith K, Isaakidis P, Ali E, Hinderaker SG, Ogtay G, Ramsay A, Jalolov A, Dara M.

PLoS One. 2017 May 4;12(5):e0176473. doi: 10.1371/journal.pone.0176473. eCollection 2017.

18.

Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience.

Sinkou H, Hurevich H, Rusovich V, Zhylevich L, Falzon D, de Colombani P, Dadu A, Dara M, Story A, Skrahina A.

Eur Respir J. 2017 Mar 22;49(3). pii: 1602049. doi: 10.1183/13993003.02049-2016. Print 2017 Mar. No abstract available.

19.

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.

van der Werf MJ, Hollo V, Ködmön C, Dara M, Catchpole M.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601992. doi: 10.1183/13993003.01992-2016. Print 2017 Mar. No abstract available.

20.

Breaking the barriers: Migrants and tuberculosis.

Sotgiu G, Dara M, Centis R, Matteelli A, Solovic I, Gratziou C, Rendon A, Battista Migliori G.

Presse Med. 2017 Mar;46(2 Pt 2):e5-e11. doi: 10.1016/j.lpm.2017.01.013. Epub 2017 Feb 28. Review.

PMID:
28256381
21.

The role of novel molecular techniques for tuberculosis diagnostics in the WHO European Region.

Ehsani S, van den Boom M, Gilpin C, Dara M; WHO Regional Office for Europe.

J Public Health (Oxf). 2016 Dec 2;38(4):824-825. doi: 10.1093/pubmed/fdv200. No abstract available.

PMID:
28158739
22.

Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience.

Skrahina A, Hurevich H, Falzon D, Zhilevich L, Rusovich V, Dara M, Setkina S.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S62-S63. doi: 10.1016/j.ijmyco.2016.11.014. Epub 2016 Nov 23.

23.

European policies in the management of tuberculosis among migrants.

D'Ambrosio L, Centis R, Dara M, Solovic I, Sulis G, Zumla A, Migliori GB.

Int J Infect Dis. 2017 Mar;56:85-89. doi: 10.1016/j.ijid.2016.11.002. Epub 2016 Nov 9.

24.

TB and HIV co-infection in children: do we know enough?

Dara M.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1422. No abstract available.

PMID:
27776579
25.

Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.

Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Tran R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Teixeira V, Ward B, Gratziou C, Migliori GB.

Eur Respir J. 2016 Sep;48(3):808-17. doi: 10.1183/13993003.00840-2016. Epub 2016 Aug 4.

26.

Variation in policy and practice of adolescent tuberculosis management in the WHO European Region.

Blok N, van den Boom M, Erkens C, Dara M, van den Hof S.

Eur Respir J. 2016 Sep;48(3):943-6. doi: 10.1183/13993003.00704-2016. Epub 2016 Jul 28. No abstract available.

27.

Preventing and controlling tuberculosis among refugees in Europe: more is needed.

Dara M, Solovic I, Goletti D, Sotgiu G, Centis R, D'Ambrosio L, Ward B, Teixeira V, Gratziou C, Migliori GB.

Eur Respir J. 2016 Jul;48(1):272-4. doi: 10.1183/13993003.00329-2016. No abstract available.

28.

High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates.

Khashei R, Dara M, Bazargani A, Bagheri Lankarani K, Taghavi A, Moeini M, Dehghani B, Sohrabi M.

APMIS. 2016 Sep;124(9):787-93. doi: 10.1111/apm.12567. Epub 2016 Jun 30.

PMID:
27357065
29.

Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease.

Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Ward B, Teixeira V, Gratziou C, Migliori GB.

Eur Respir J. 2016 May;47(5):1345-7. doi: 10.1183/13993003.00377-2016. Epub 2016 Mar 23. No abstract available.

30.

Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009-2010.

Milanov V, Falzon D, Zamfirova M, Varleva T, Bachiyska E, Koleva A, Dara M.

Int J Mycobacteriol. 2015 Jun;4(2):131-7. doi: 10.1016/j.ijmyco.2015.03.005. Epub 2015 Apr 17.

31.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Review.

32.

High time to use rapid tests to detect multidrug resistance in sputum smear-negative tuberculosis in Belarus.

Rusovich V, Kumar AM, Skrahina A, Hurevich H, Astrauko A, de Colombani P, Tayler-Smith K, Dara M, Zachariah R.

Public Health Action. 2014 Dec 21;4(4):243-8. doi: 10.5588/pha.14.0069.

33.

Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward.

Acosta CD, Dadu A, Ramsay A, Dara M.

Public Health Action. 2014 Oct 21;4(Suppl 2):S3-S12. doi: 10.5588/pha.14.0087. Review.

34.

First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis.

Alikhanova N, Akhundova I, Seyfaddinova M, Mammadbayov E, Mirtskulava V, Rüsch-Gerdes S, Bayramov R, Suleymanova J, Kremer K, Dadu A, Acosta CD, Harries AD, Dara M.

Public Health Action. 2014 Oct 21;4(Suppl 2):S17-23. doi: 10.5588/pha.14.0049.

35.

Performance of decentralised facilities in tuberculosis case notification and treatment success in Armenia.

Davtyan K, Zachariah R, Davtyan H, Ramsay A, Denisiuk O, Manzi M, Khogali M, Van den Bergh R, Hayrapetyan A, Dara M.

Public Health Action. 2014 Oct 21;4(Suppl 2):S13-6. doi: 10.5588/pha.14.0038.

36.

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.

Gadoev J, Asadov D, Tillashaykhov M, Tayler-Smith K, Isaakidis P, Dadu A, de Colombani P, Gudmund Hinderaker S, Parpieva N, Ulmasova D, Jalolov A, Hamraev A, Ali E, Boom Mv, Hammerich A, Gozalov O, Dara M.

PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015.

37.

Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011-2015: Cost-effectiveness analysis.

Jakab Z, Acosta CD, Kluge HH, Dara M.

Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S212-6. doi: 10.1016/j.tube.2015.02.027. Epub 2015 Mar 6.

PMID:
25829287
38.

Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium.

D'Ambrosio L, Tadolini M, Centis R, Duarte R, Sotgiu G, Aliberti S, Dara M, Migliori GB.

Int J Infect Dis. 2015 Mar;32:156-60. doi: 10.1016/j.ijid.2014.12.024.

39.

Tuberculosis control in prisons: current situation and research gaps.

Dara M, Acosta CD, Melchers NV, Al-Darraji HA, Chorgoliani D, Reyes H, Centis R, Sotgiu G, D'Ambrosio L, Chadha SS, Migliori GB.

Int J Infect Dis. 2015 Mar;32:111-7. doi: 10.1016/j.ijid.2014.12.029. Review.

40.

Untreatable tuberculosis: is surgery the answer?

Dara M, Sotgiu G, Zaleskis R, Migliori GB.

Eur Respir J. 2015 Mar;45(3):577-82. doi: 10.1183/09031936.00229514. No abstract available.

41.

Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination.

Davtyan K, Hayrapetyan A, Dara M, Gillini L, Davtyan H, Centis R, D'Ambrosio L, Sotgiu G, Migliori GB.

Eur Respir J. 2015 Jan;45(1):289-91. doi: 10.1183/09031936.00118514. No abstract available.

42.

Conflict and drug-resistant tuberculosis in Ukraine.

Acosta CD, Kaluski DN, Dara M.

Lancet. 2014 Oct 25;384(9953):1500-1. doi: 10.1016/S0140-6736(14)61914-0. No abstract available.

PMID:
25390570
43.

A new roadmap for childhood tuberculosis.

Acosta CD, Rusovich V, Harries AD, Ahmedov S, van den Boom M, Dara M.

Lancet Glob Health. 2014 Jan;2(1):e15-7. doi: 10.1016/S2214-109X(13)70153-0. Epub 2013 Dec 19. No abstract available.

44.

Tuberculosis prevention and control in prisons: do we know enough?

Dara M, Acosta CD.

Int J Tuberc Lung Dis. 2014 Jul;18(7):758-9. doi: 10.5588/ijtld.14.0362. No abstract available.

PMID:
24902546
45.

ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.

Esposito S, D'Ambrosio L, Tadolini M, Schaaf HS, Caminero Luna J, Marais B, Centis R, Dara M, Matteelli A, Blasi F, Migliori GB.

Eur Respir J. 2014 Sep;44(3):811-5. doi: 10.1183/09031936.00060414. Epub 2014 May 15. No abstract available.

46.

Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.

Zignol M, Dara M, Dean AS, Falzon D, Dadu A, Kremer K, Hoffmann H, Hoffner S, Floyd K.

Drug Resist Updat. 2013 Dec;16(6):108-15. doi: 10.1016/j.drup.2014.02.003. Epub 2014 Feb 28. Review.

47.

Tuberculosis elimination: theory and practice in Europe.

D'Ambrosio L, Dara M, Tadolini M, Centis R, Sotgiu G, van der Werf MJ, Gaga M, Cirillo D, Spanevello A, Raviglione M, Blasi F, Migliori GB; European national programme representatives.

Eur Respir J. 2014 May;43(5):1410-20. doi: 10.1183/09031936.00198813. Epub 2014 Jan 3.

48.

Bacille Calmette-Guérin vaccination: the current situation in Europe.

Dara M, Acosta CD, Rusovich V, Zellweger JP, Centis R, Migliori GB; WHO EURO Childhood Task Force members.

Eur Respir J. 2014 Jan;43(1):24-35. doi: 10.1183/09031936.00113413. No abstract available.

49.

Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.

Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D.

Euro Surveill. 2013 Oct 17;18(42). pii: 20609.

50.

First joint meeting of three European tuberculosis networks.

van der Werf MJ, Erkens C, Gebhard A, Voitzwinkler F, Dara M.

Euro Surveill. 2013 Sep 12;18(37). pii: 20583. No abstract available.

Supplemental Content

Support Center